Nemaura Medical Inc. (NMRD)
Stock Price:
$4.26 USD
0.00 (0.00%)
Updated November 27, 1:00 PM EST - Market closed
Key Info
| Market Cap |
97.59M |
| Revenue (ttm) |
n/a |
| Net Income (ttm) |
-4.47M |
| Shares Out |
22.91M |
| EPS (ttm) |
-0.21 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
November 27 |
| Last Price |
$4.26 |
| Previous Close |
$4.26 |
| Change ($) |
0.00 |
| Change (%) |
0.00% |
| Day's Open |
4.24 |
| Day's Range |
4.17 - 4.28 |
| Day's Volume |
8,100 |
| 52-Week Range |
2.50 - 16.50 |
More Stats
| Market Cap |
97.59M |
| Enterprise Value |
85.86M |
| Earnings Date (est) |
Feb 5, 2021 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
22.91M |
| Float |
8.77M |
| EPS (basic) |
-0.20 |
| EPS (diluted) |
-0.21 |
| FCF / Share |
-0.21 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
96,268 |
| Short Ratio |
3.35 |
| Short % of Float |
1.10% |
| Beta |
-0.51 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
n/a |
| PB Ratio |
8.44 |
| Revenue |
n/a |
| Operating Income |
-4.55M |
| Net Income |
-4.47M |
| Free Cash Flow |
-4.68M |
| Net Cash |
11.73M |
| Net Cash / Share |
0.51 |
| Gross Margin |
n/a |
| Operating Margin |
n/a |
| Profit Margin |
n/a |
| FCF Margin |
n/a |
| ROA |
-27.30% |
| ROE |
-78.21% |
| ROIC |
-282.10% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Ratings (1)
| Buy |
1 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
14.0
Current: $4.26
High
14.0
Target: 14.00
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|
| Revenue | - | - | - | - | - | - | - | - |
| Operating Income | -4.78 | -4.48 | -1.91 | -1.55 | -1.54 | -1.32 | -0.59 | -0.83 |
| Net Income | -4.16 | -4.45 | -1.82 | -1.55 | -1.54 | -1.32 | -0.59 | -0.83 |
| Shares Outstanding | 20.81 | 18.09 | 15.01 | 20.50 | 20.17 | 20.00 | 18.53 | 18.00 |
| Earnings Per Share | -0.20 | -0.25 | -0.10 | - | - | -0.10 | - | - |
| Operating Cash Flow | -3.45 | -3.56 | -2.14 | -1.19 | -1.21 | -1.43 | 1.50 | -0.77 |
| Capital Expenditures | -0.21 | -0.08 | -0.05 | -0.08 | -0.01 | -0.02 | - | -0.03 |
| Free Cash Flow | -3.66 | -3.64 | -2.18 | -1.27 | -1.22 | -1.45 | 1.50 | -0.80 |
| Cash & Equivalents | 0.11 | 3.74 | 5.73 | 7.14 | 9.40 | 0.35 | 1.96 | 0.20 |
| Net Cash / Debt | 0.11 | 3.74 | 5.73 | 7.14 | 9.40 | 0.35 | 1.96 | 0.20 |
| Assets | 1.22 | 4.76 | 6.26 | 7.40 | 9.73 | 0.91 | 2.05 | 0.26 |
| Liabilities | 2.53 | 2.54 | 2.14 | 2.04 | 2.05 | 1.83 | 1.68 | - |
| Book Value | -1.31 | 2.23 | 4.11 | 5.37 | 7.68 | -0.92 | 0.37 | 0.26 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Nemaura Medical Inc. |
| Country |
United States |
| Employees |
17 |
| CEO |
Dewan Fazlul Hoque Chowdhury |
Stock Information
| Ticker Symbol |
NMRD |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: NMRD |
Description
Nemaura Medical, a medical technology company, discovers, develops, and commercializes diagnostic medical devices. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. It has a license agreement with Healthimation, LLC, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for Type 2 diabetes, prediabetes, and general wellness; the Why WAIT app; and common law trademarks which incorporate the mark WHY WAIT or WHYWAIT and the use of licensed marks. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.